Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

Recruiting NCT07703683

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Conditions: Diabetes, Obesity & Overweight, Cushing Syndrome, Metabolic Diseases, Endocrine Diseases, Sarcopenia, Sarcopenic Obesity

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 100

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Location: Cliniques Universitaires Saint-Luc Woluwe-Saint-Pierre - Sint-Pieters-Woluwe

Summary

Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population. .

Eligibility Criteria

Inclusion Criteria: * Metabolic or endocrine disease Exclusion Criteria: * Known myopathy * Systemic steroid use (\> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome * Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol * History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07703683). StuddyBuddy aggregates publicly available trial information.